Your Messages Inbox
Your Article Summary
See Latest ArticlesFDA actions in brief, June 2009 (Avastin, Azor, Exforge HCT, Cycloset, ACTOplus met XR, Lamictal ODT, Dysport, Creon)
Formulary , 06/11/09
Bevacizumab was approved for use as a single agent for the treatment of patients with progressive glioblastoma after prior therapy. The combination of amlodipine and olmesartan was approved for first-line therapy in patients likely to need multiple antihypertensive agents to achieve their blood pressure goals.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor